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Less asked is the question of how much money will be
required to contain an epidemic growing as fast as
Russia’s, or whether the money is going to those most at
risk. Indeed, preliminary signs suggest that even as for-
eign assistance pours into Russia, there are few mecha-
nisms to ensure that the injection drug users who consti-
tuted 80% of registered HIV infections as of 2004, or the
sex workers and sexual partners of drug users bearing the
brunt of new infections, will be reached. Key to this
process will be the Russian federal government, which
has been ambivalent at best about the peer outreach pro-
grams and specialized non-governmental organizations
critical to containing epidemics concentrated among
highly stigmatized groups in other countries. 
Uncertain Data:Testing and Tracking HIV in Russia
Post-Soviet Russia is in a state of constant, if uncertain,
renovation. It is not uncommon, stepping into a newly
made-over hotel or recently refurbished metro station, to
feel something shift slightly under foot, as if the rich new
tile had been laid over a slightly unstable foundation.
New efforts at tracking the arc of the HIV epidemic in
Russia, and recent announcements that new HIV cases
are down and that the epidemic is “generalizing” to
include those infected sexually rather than through injec-
tion drug use, may be seen as resting on similarly uncer-
tain ground. 
Even the most basic facts, such as the number of
those with HIV in the country, remain points of con-
tention. The United Nations has for four years running
given Russia the dubious distinction of having the fastest
growing HIV epidemic in the world. Where virtually 
no cases of HIV were recorded in Russia a decade ago,
today the best estimates of UN epidemiologists put 
the number of those with HIV at as high as 1.2 million,
more than in all of North America. Unlike the American
and European epidemics, HIV in Russia has hit with
explosive force among the young, most particularly
among the young who inject drugs. Four of five of those
infected are under 30, and some 80% of those with HIV
became infected through sharing a contaminated needle.
The epidemic has coincided both with severe economic
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dislocation that has helped fuel drug use, and with a
1998 tightening of drug laws that made possession of
illicit drugs—including the residue in a used syringe—
punishable by prolonged imprisonment. One hundred
thousand Russians were convicted in the first year follow-
ing passage of the new penalties, and the number of
those jailed for drug offenses increased five-fold between 
1997 and 2000. Until penal code reform in 2004, mass 
incarceration effectively forced infected and uninfected
individuals into environments where risk behavior such
as drug use and sex continued, but where protections
such as sterile injection equipment were unavailable.
International epidemiologists say the result was unprece-
dented acceleration of HIV and TB, and vast numbers of
undiagnosed infections.
Federal officials in Russia, by contrast, doggedly
focus on the visible tip of the iceberg. Those connected
with state security services, particularly, dismiss interna-
tional estimates as empty speculation, insisting instead
that the number of those with HIV is the number of cases
officially registered: 311,000 cases as of May 2005. Even
those officials who recognize that registered HIV cases
reflect only a small portion of total HIV burden in any
country, such as Federal AIDS Center head Vadim
Pokrovsky, have in recent years reported that the number
of new infections in Russia has decreased sharply, and
that new cases are increasingly found among women
infected sexually. In 2000, for example, women account-
ed for 21 percent of new HIV infections in Russia, while
in 2003 they represented 33 percent. Suggestions that the
worst spike in infections may be past and that the epidem-
ic is generalizing have in turn been challenged by Western
analysts. Murray Feshbach of the Woodrow Wilson
International Center for Scholars points out that the drop
in cases among drug users corresponds to sharp reduc-
tions in HIV tests administered and a sharp increase in
the number of cases whose origin went unrecorded.
Between 2000 and 2003, the number of HIV tests admin-
istered in Russia fell by nearly 3 million. By that period’s
end, half of new HIV cases were logged without noting
the main risk factor for infection. 
Whatever the disagreements about HIV trends in
Russia, there is no question that the epidemic poses 
challenges unfamiliar to the donor countries coordinating
global AIDS relief. With the exception of China, no coun-
try in the world is grappling with HIV prevention and treat-
ment with a pool of 800,000 young HIV-infected drug
users. Injection driven HIV epidemics spread faster than
sexually transmitted ones, and in some Russian
provinces—such as Irkutsk in Siberia, the Russian region
with the highest number of HIV infections per capita—
nearly 65% of drug users are already HIV positive. While
the Russian epidemic is still too young for the country to
have experienced the wave of AIDS deaths that washed
over the U.S. or Africa, there is every reason to expect sub-
stantial suffering and loss in the near future. HIV out-
breaks have now been documented in 82 of the country’s
89 regions. Of the estimated 60,000 in urgent need of
HIV treatment, the World Health Organization estimates
that 2,000 have access to antiretroviral medications. 
Federal Ambivalence
One can only imagine how much uglier the already dark
history of HIV in the U.S. would look if poor drug users,
rather than gay men of means, had been the overwhelm-
ing majority of those infected. In Russia, the federal gov-
ernment responded to its own AIDS crisis with a strate-
gy pioneered by Washington in the 1980s: denial.
Privately, Russian officials observed that the death of
large numbers of undesirables did not seem a crisis, and
informed drug users at hospitals that their lack of social
worth made them ineligible for treatment. In public, it
was not until a 2003 speech by Putin that a Russian
President mentioned the epidemic. While international
donors such as Open Society Institute, DFID, and
Médecins du Monde funded needle exchange programs
proven to reduce HIV transmission among injection
drug users, the federal government’s HIV prevention
budget was a paltry $1 million. Officials and coordinating
groups responsible for HIV prevention have been repeat-
edly shuffled and combined. As late as 2001, HIV treat-
ment, when offered, was usually with a single Russian-
made drug rather with than with the combination of anti-
retroviral medications that had long been the global stan-
dard of care. In an attitude characteristic of its dislike of
receiving handouts or advice from outsiders, the Russian
government was a donor to the Global Fund but was
reluctant to be an applicant: the first Russian request 
to the Fund was filed by a consortium of NGOs, at a 
time when Russia had yet to form the “country 
coordinating mechanism” (CCM), including government
representatives, that was usually required. 
Against that backdrop of inaction, recent years have
held some promise for the Russian response to HIV.
People with HIV have become more vocal, forming net-
works of organizations, staging protests, and initiating dia-
logue with government officials. The government has
formed an official CCM for the Global Fund, and has con-
solidated AIDS programs in the Ministry of Health and
Social Development. The Russian government signed 
the World Bank Loan, including a promise to support 
thirty harm reduction projects serving active drug users.
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The first Global Fund grant, known as GLOBUS, is set to
deliver state of the art HIV treatment to the first 1200
patients by year’s end, and has consciously included drug
users among those to be reached. The program also sup-
ports twenty-three needle exchange projects in the ten
regions in which it is focused. A second Global Fund grant,
this one awarded to a government-controlled NGO rather
than an independent one, intends to bring the total 
of those receiving HIV treatment to 74,000 by 2010. 
The Joint United Nations Programme on HIV/AIDS
(UNAIDS) recently held a press conference to announce its
effort to support a unified response to the epidemic: one
agreed upon framework for action, one national AIDS
coordinating authority, and one system for monitoring 
and evaluation.
Nonetheless, the UN’s “three ones” may not add up
to anywhere near enough for the Russians most vulnera-
ble to HIV. In spite of international attention and the
spike in oil revenues that has provided a steady boost to
the Russian economy, a recent survey found that funding
for needle exchange programs had actually fallen by 
29 percent since 2002. Russian drug control authorities
circulated a memo in November 2003 advising that 
needle exchanges were in violation of laws prohibiting 
promotion of drug use, and where possible should be
shut down. While that memorandum was countered 
by expressions of support for syringe exchange by the
Ministry of Health, programs are operating in a legal
limbo, and a government order clarifying official guide-
lines for syringe exchange remains stalled somewhere
between the law enforcement authorities and the
Ministry of Health. Early drafts of this order have called
for an end to needle exchange by peer outreach workers,
a key component for successful programs in a country
where many drug users hesitate to come to central 
locations for fear of shakedowns by the police or the 
addition of their names to lists kept by government
authorities. Oral substitution treatment, an approach
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used throughout the U.S. and Europe that offers medica-
tions such as methadone to drug users so that they can
refrain from injecting, remains illegal in Russia in spite
of repeated studies demonstrating its efficacy in reducing
HIV risk behavior, HIV infection, and crime. Russian
officials steadfastly resist any language supportive of sub-
stitution treatment in UN documents.
Indeed, increased general awareness of the dangers of
HIV may be providing a pretext for Russians to turn away
from targeted efforts to address those in greatest danger.
During a recent visit to Washington, a visiting Duma
member noted that since only 65% of new HIV infections
in Russia were now among drug users, it was beyond dis-
pute that 35% of those with HIV had done nothing wrong
and deserved public support. The implication, that those
who used drugs deserved what they got, including death
from AIDS, is one echoed all too regularly in government
offices and health care facilities in Russia. Funders who
have been providing “bridge funding” for needle exchange
programs until the Russian government directs World
Bank funds toward their support have begun to wonder if
this approach is a bridge to nowhere: More than two years
after signing the loan, the government has yet to deliver
substantial support to a single harm reduction project. 
A national administrative reform effective in January 2005
transferred responsibility for much government spending,
including many AIDS treatment and prevention efforts, to
regional governments.
Local Adaptation and International Influence
Some regional legislators, recognizing the threat posed
by the HIV epidemic, have been more responsive to HIV,
contributing funds as they can to needle exchange and 
to the AIDS Centres offering HIV treatment in Russia.
This support, however, is neither universal nor sufficient-
ly widespread to approach anything near the levels of 
coverage needed to contain injection driven epidemics.
In Moscow, for example, where most people with HIV
live, there is not a single needle exchange program to 
provide injectors with sterile injection equipment. 
The head of the city health department has announced
that there is no crisis in HIV treatment, since drug 
users do not need it. As for efforts to contain the sexual-
ly transmitted epidemic, the Moscow City Duma in May
2005 announced a $1 million education campaign declar-
ing “there is no such thing as safer sex.” 
In a strange twist, Russian policy—including oppo-
sition to needle exchange programs, zero-tolerance
approaches to drug use, and appeals to sexual absti-
nence—finds its strongest ally in the nation that used 
to be Russia’s greatest competitor. While most European
nations have implemented needle exchange programs,
the U.S. remains the only nation in the world to bar feder-
al funding for sterile injection equipment to drug users.
None of the more than $11 million the U.S. currently pro-
vides to Russian HIV/AIDS programs goes for clean 
needles. It is difficult to know, if Russia is selected for
greater engagement on HIV/AIDS by the U.S., whether
the increased attention will be a blessing or a curse for
those programs working to bring HIV prevention to drug
users. As the world’s largest donor to HIV relief and the
most influential player in the politics of development, the
U.S. has recently sought to make its opposition to needle
exchange into the global standard: at a recent UNAIDS
meeting, only unified opposition from other member
states prevented the U.S. from successfully striking all
language about access to sterile injection equipment from
a global HIV prevention strategy document.
For their part, Russian programs seeking to reach
drug users with HIV prevention and treatment are looking
beyond their own government or that of the U.S. This past
summer, a group of NGOs, including the Russian Harm
Reduction Network and the Russian Community of People
Living with HIV, applied to the Global Fund to sharply
increase the availability of clean needles and condoms in
the 79 Russian regions not covered by earlier grants.
Russia’s country coordinating mechanism, which includes
a high-ranking official at the Ministry of Health, the presi-
dent of the Russian Academy of Medical Sciences, and his
son, the head of the Federal AIDS Center, did not support
the application. 
As of this writing, the Fund’s decision on the applica-
tion is unknown. So too is the fate of the millions at risk
for HIV infection through drug use in Russia, and in the
many countries, such as those in Central Asia, that take
their cue on HIV policy from decisions made in Moscow.
Dozens of studies in developed and developing countries
alike have demonstrated clearly that needle exchange and
substitution treatment work to save lives without encour-
aging drug use. Whether evidence will prove any match
for ideology in Russia, or in the corridors of key donor
governments, remains anybody’s guess.
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